QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9667723F46F28605F09734A99CA4DA2;jsessionid=6961CF836CF5728373E2183EADAB2533;jsessionid=2895DFEDBF1325C8CD2C502532774450;jsessionid=33C9460D4831AA6D3B7A709D82A8F842;jsessionid=8D5BA59B60A1709E6B5F9C101B9EFDE3;jsessionid=0E17F8052A78D5476CA2E699690A9237;jsessionid=5B9872E98BB8E4C0A686CBD7D1F69879;jsessionid=C64523603CE4B8AF838291B28F59DEDF;jsessionid=8DF12D58D29F905A2132CE0C6520BFEE;jsessionid=B1898FE53EEB1995B0307F9098B911F7 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9667723F46F28605F09734A99CA4DA2;jsessionid=6961CF836CF5728373E2183EADAB2533;jsessionid=2895DFEDBF1325C8CD2C502532774450;jsessionid=33C9460D4831AA6D3B7A709D82A8F842;jsessionid=8D5BA59B60A1709E6B5F9C101B9EFDE3;jsessionid=0E17F8052A78D5476CA2E699690A9237;jsessionid=5B9872E98BB8E4C0A686CBD7D1F69879;jsessionid=C64523603CE4B8AF838291B28F59DEDF;jsessionid=8DF12D58D29F905A2132CE0C6520BFEE;jsessionid=B1898FE53EEB1995B0307F9098B911F7